Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Urology|February 14, 2015
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell CarcinomaMichael Chevinsky, Mariam Imnadze, Alexander Sankin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 22, 2021
Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?Ari P Bernstein, Meenakshi Davuluri, Matthew DeMasi, et al.
The Journal of Urology|November 19, 2024
Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal GelPhillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, et al.
Clinical Genitourinary Cancer|July 31, 2025
Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer With UGN-102: Outcomes From the 5-Year Long-Term Extension Study of the Single-Arm, Phase 2b Optima II StudyNeal D Shore, K Kent Chevli, Daniel Saltzstein, et al.
Cancer Medicine|August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional samplingAlexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Nature Reviews. Urology|April 26, 2019
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018Yair Lotan, Trinity J Bivalacqua, Tracy Downs, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|July 28, 2021
Resource-efficient pooled sequencing expands translational impact in solid tumorsRenzo G DiNatale, Roy Mano, Vladimir Makarov, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023Monika Joshi, Leonard Tuanquin, Junjia Zhu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
The Journal of Urology|August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm TrialK Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Pageof 4